8100EGP
- Active ingredient
- alteplase
- Strength
- 50 mg
- Form
- vial
- Manufacturer
- genentech > egyptian pharmaceutical trading company
- Route
- injection
Uses
Restoration of function in occluded central venous access devices and thrombolytic therapy in approved settings.
Do not use if
Known hypersensitivity to alteplase or formulation components.
Side effects
Bleeding, hypersensitivity reactions, infection-related complications.
Warnings
Bleeding risk requires careful monitoring during and after administration.
How it works
Recombinant tissue plasminogen activator that converts plasminogen to plasmin and dissolves fibrin clots.
Storage
Store according to manufacturer instructions and protect lyophilized product appropriately.
